The relevance of its mechanism of action for pulmonary fibrosis is unclear; nintedanib has been reported to reduce SERPINH1 mRNA levels but not HSP47 protein levels in TGF-β1–treated IPF fibroblasts in vitro [75]. Here, SERPINH1 is linked to pulmonary fibrosis.